India to Poland: Velpatasvir Export Trade Route

The India to Poland Velpatasvir corridor is one of India's established pharmaceutical export routes, with 55 shipments documented worth a combined $3.5M USD. The route is dominated by MYLAN LABORATORIES LIMITED , which alone accounts for roughly 89% of all export value, reflecting the consolidated nature of India's velpatasvir manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $63.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with velpatasvir's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 13.6%, placing it at rank #8 among India's top velpatasvir export destinations globally.

On the import side, key buyers of Indian velpatasvir in Poland include STATE ENTERPRISE UKRVAKTSYNA , STATE ENTERPRISE UKRVAKTSYNA, , OST WEST EXPRESS and 18 others. STATE ENTERPRISE UKRVAKTSYNA is the single largest importer with 1 shipments valued at $1.6M USD.

India's velpatasvir exports to Poland are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Poland benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED , EURO LIFECARE PRIVATE LIMITED, MYLAN LABORATORIES LIMITED — together account for 97% of total trade value on this route. The average shipment value of $63.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as velpanat film coated tablets of 400 mg 100 mg 28 film coated tablets in a bottle sofosbuvir and velpatasvir 400mg 100mg and velpanat-film-coated tablets of 400 mg/100 mg 28,film-coated tablets in a bottle(sofosbuvir and velpatasvir 400mg/100mg), suggesting that buyers in Poland tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, STATE ENTERPRISE UKRVAKTSYNA is the largest importer with 1 shipments worth $1.6M USD — representing 45% of all velpatasvir imports from India on this route. A total of 21 buyers are active on this corridor.